10-Q: CLS Holdings USA Reports Narrowed Net Loss in Q2 2025 Amidst Revenue Decline
Quarterly Report
CLS Holdings USA, Inc. reports a reduced net loss for the quarter ended November 30, 2024, despite a decrease in revenue compared to the same period last year.
Summary
- CLS Holdings USA, Inc. reported a net loss of $87,671 for the three months ended November 30, 2024, a significant improvement from the $1,302,180 loss in the same period of 2023.
- The company's revenue decreased to $4,161,270 for the quarter, down from $5,197,214 in the prior year, with both dispensary and production revenues experiencing declines.
- Cost of goods sold decreased to $2,389,245, reflecting the lower sales volume, while selling, general, and administrative expenses also decreased to $2,095,099 due to cost-cutting measures.
- Interest expense decreased to $295,715, primarily due to reduced principal balances on notes and debentures.
- The company recorded a gain on settlement of debt of $949,793 related to the payment of notes payable.
- For the six months ended November 30, 2024, the net loss was $908,534, compared to $1,763,913 in the same period of 2023, with revenue at $8,966,435, down from $10,311,741.
- The company's working capital deficit was $13,116,227 as of November 30, 2024, primarily due to tax accruals under Section 280E of the Internal Revenue Code.
Sentiment
Score: 6
Explanation: The document shows a mixed picture. While the company has made progress in reducing its net loss and operating expenses, it still faces significant challenges related to revenue decline, debt levels, and working capital deficit. The positive steps taken are encouraging, but the company's future success is not guaranteed.
Positives
- The company significantly reduced its net loss compared to the same quarter last year.
- Selling, general, and administrative expenses were reduced due to cost-cutting efforts.
- Interest expenses decreased due to reduced principal balances on notes and debentures.
- The company recorded a substantial gain on settlement of debt.
- The company generated positive cash flow from operating activities for the six months ended November 30, 2024.
- The company has been actively reducing its debt burden through settlements, restructurings, principal payments, and conversions of debt to common stock.
Negatives
- The company experienced a decrease in revenue compared to the same quarter last year.
- The company has a significant working capital deficit.
- The company's auditors have included a going concern qualification in their audit report.
- The company is subject to Section 280E of the Internal Revenue Code, which limits deductions for cannabis businesses.
Risks
- The company's ability to continue as a going concern is dependent on generating sufficient cash from operations or obtaining necessary financing.
- The company faces risks related to the cannabis industry, including regulatory changes and market acceptance.
- The company's operations are subject to Section 280E of the Internal Revenue Code, which limits deductions for cannabis businesses.
- The company has a significant working capital deficit, primarily due to tax accruals under Section 280E.
- The company's future performance is subject to various risks and uncertainties, including the impact of climate change on its operations.
Future Outlook
The company intends to continue its efforts to reduce its debt burden and focus on operational activities to improve cash flow. They also plan to explore opportunities for growth through acquisitions, joint ventures, and licensing agreements. The company is planning a potential capital expenditure project for a cannabis consumption lounge.
Management Comments
- Management intends to finance operating costs over the next twelve months with revenues from operations.
- Management believes that they can ultimately establish a position as one of the premier cannabinoid extraction and processing companies in the industry.
- Management intends to continue efforts to further reduce the debt burden in the coming year.
- Management believes they have resources in place with existing and prospective lenders to continue to reduce the debt burden.
- Management believes the resources are available to execute the business plan in the coming year from existing and prospective investors and from internally generated cash flow.
Industry Context
The company operates in the cannabis industry, which is subject to evolving regulations and market dynamics. The company's focus on vertical integration and brand development aligns with industry trends towards establishing strong market positions. The company's efforts to reduce debt and improve cash flow are critical for long-term sustainability in a competitive market.
Comparison to Industry Standards
- The company's gross margin of approximately 42-43% is within the range of other cannabis companies, but there is room for improvement.
- The company's operating expenses as a percentage of revenue are high, indicating a need for further cost control.
- The company's debt levels are high compared to industry averages, highlighting the need for continued debt reduction efforts.
- The company's focus on a vertically integrated model is similar to other successful cannabis companies, such as Curaleaf and Trulieve, which have demonstrated the benefits of controlling the entire supply chain.
- The company's efforts to create a national brand are similar to other companies like Canopy Growth and Tilray, which are focused on building brand recognition and loyalty.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Operating Officer | Joseph Ramalho | 2024-12-17 | Termination of employment |
Related Party Transactions
- The company issued a note payable to a related party in the principal amount of $2,600,000, with $2,200,000 converted to common stock.
- The company issued a note payable to a related party in the principal amount of $150,000.
- The company acquired and cancelled 1,125,000 shares of common stock from a board member at a cost of $40,000.
- Three of the four secured promissory notes issued on January 7, 2025, with an aggregate principal amount of $900,000, are payable to related parties.
Stakeholder Impact
- Shareholders may be concerned about the company's revenue decline and working capital deficit, but encouraged by the reduced net loss and debt reduction efforts.
- Employees may be affected by cost-cutting measures and potential changes in operations.
- Customers may be impacted by any changes in product offerings or service levels.
- Suppliers may be affected by the company's financial condition and payment terms.
- Creditors may be concerned about the company's debt levels and ability to repay obligations.
Next Steps
- The company intends to continue its efforts to reduce its debt burden.
- The company plans to focus on operational activities to further improve cash flow.
- The company is exploring opportunities for growth through acquisitions, joint ventures, and licensing agreements.
- The company is planning a potential capital expenditure project for a cannabis consumption lounge.
Key Dates
| Date | Description |
|---|---|
| 2011-03-31 | CLS Holdings USA, Inc. was originally incorporated as Adelt Design, Inc. |
| 2014-05-01 | CLS Labs was originally incorporated in the state of Nevada under the name RJF Labs, Inc. |
| 2014-11-20 | CLS Holdings USA, Inc. adopted amended and restated articles of incorporation, changing its name from Adelt Design, Inc. |
| 2015-04-29 | CLS Holdings USA, Inc. entered into a merger agreement with CLS Labs. |
| 2018-06-27 | Acquisition of Alternative Solutions. |
| 2018-12-12 | Date of the Canaccord Debentures. |
| 2024-08-28 | Date of Promissory Note 9 (PN9) issuance. |
| 2024-08-30 | Conversion of $2,200,000 of PN9 into common stock. |
| 2024-09-10 | Settlement of three notes payable using proceeds from PN9. |
| 2024-10-15 | Date of Promissory Note 10 (PN10) issuance. |
| 2024-11-01 | Acquisition and cancellation of shares from a board member. |
| 2024-11-30 | End of the quarterly period. |
| 2024-12-17 | Termination of the Chief Operating Officer. |
| 2024-12-27 | Amendment to the Canaccord Debentures. |
| 2025-01-07 | Issuance of four secured promissory notes. |
| 2025-01-08 | Number of shares outstanding as of this date. |
| 2025-01-10 | Date of report signature. |
Keywords
cannabis, dispensary, extraction, wholesale, debt, net loss, revenue, operating expenses, financial results, going concern
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.